Dr. Judith Anne Shizuru, MD, PhD

Dr. Shizuru practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Shizuru's NPI, 1003942251, was assigned on February 24, 2007. Dr. Shizuru graduated from Stanford University School Of Medicine in 1992. Dr. Shizuru holds California license G79769.

Dr. Shizuru's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Shizuru's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Shizuru to 1 more hospital and 1 medical group, each named with a free account. Dr. Shizuru's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shizuru practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shizuru's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Shizuru is board certified in internal medicine by the American Board of Internal Medicine. Dr. Shizuru is licensed in California.

Dmand AI lists chronic leukemia and multiple myeloma among the conditions Dr. Shizuru treats.

CMS data shows 83 Medicare services from Dr. Shizuru across 1 procedure code in 2024, all of them office visits, for 46 Medicare patients. Medicare paid $10,474 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 46 Medicare patients who saw Dr. Shizuru in 2024. The largest group is 65 to 74, with 30 patients. 61% of them have high blood pressure, and 57% have high cholesterol. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shizuru's median patient age at 63, with 45% women.

In 2024, Dr. Shizuru wrote 263 Medicare Part D claims for 30 patients. 82% of them were for generic drugs. CMS names the drug for 127 of them, across 4 drugs with 11 or more claims each, at $358,211 in total drug cost. In 2023, CMS named 86 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Shizuru for performance year 2024, reported as part of a group. Dr. Shizuru accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shizuru as offering telehealth.

Dmand AI links 82 papers to Dr. Shizuru, published from 2002 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Transplantation Conditioning. Dr. Shizuru has published most often in Biol Blood Marrow Transplant. Dr. Shizuru's most frequent co-authors are Robert Lowsky, MD, Robert Stuart Negrin, MD and Sally Arai, MD.

CMS Open Payments shows 1 general payment to Dr. Shizuru from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Roche Molecular Systems, Inc. paid the most, $62.

Dr. Shizuru graduated from Stanford University School Of Medicine in 1992.

Dr. Shizuru is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.